A novel class of antimicrobials that inhibits the function of a key
disease-causing component of bacteria could be effective in fighting
methicillin-resistant Staphylococcus aureus (MRSA), one of the major
drug-resistant bacterial pathogens, according to researchers...
No comments:
Post a Comment